BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19731632)

  • 1. HLA-B27 misfolding and spondyloarthropathies.
    Colbert RA; DeLay ML; Layh-Schmitt G; Sowders DP
    Adv Exp Med Biol; 2009; 649():217-34. PubMed ID: 19731632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B27 misfolding and spondyloarthropathies.
    Colbert RA; DeLay ML; Layh-Schmitt G; Sowders DP
    Prion; 2009; 3(1):15-26. PubMed ID: 19363299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27 misfolding and ankylosing spondylitis.
    Colbert RA; Tran TM; Layh-Schmitt G
    Mol Immunol; 2014 Jan; 57(1):44-51. PubMed ID: 23993278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B27 and the pathogenesis of spondyloarthropathies.
    López de Castro JA
    Immunol Lett; 2007 Jan; 108(1):27-33. PubMed ID: 17129613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response.
    Turner MJ; Sowders DP; DeLay ML; Mohapatra R; Bai S; Smith JA; Brandewie JR; Taurog JD; Colbert RA
    J Immunol; 2005 Aug; 175(4):2438-48. PubMed ID: 16081815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunobiology of HLA-B27: variations on a theme.
    Colbert RA
    Curr Mol Med; 2004 Feb; 4(1):21-30. PubMed ID: 15011956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease.
    Turner MJ; Delay ML; Bai S; Klenk E; Colbert RA
    Arthritis Rheum; 2007 Jan; 56(1):215-23. PubMed ID: 17195225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From HLA-B27 to spondyloarthritis: a journey through the ER.
    Colbert RA; DeLay ML; Klenk EI; Layh-Schmitt G
    Immunol Rev; 2010 Jan; 233(1):181-202. PubMed ID: 20193000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27.
    Bowness P
    Annu Rev Immunol; 2015; 33():29-48. PubMed ID: 25861975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats.
    DeLay ML; Turner MJ; Klenk EI; Smith JA; Sowders DP; Colbert RA
    Arthritis Rheum; 2009 Sep; 60(9):2633-43. PubMed ID: 19714651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies.
    Mear JP; Schreiber KL; Münz C; Zhu X; Stevanović S; Rammensee HG; Rowland-Jones SL; Colbert RA
    J Immunol; 1999 Dec; 163(12):6665-70. PubMed ID: 10586062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B27 and pathogenesis of spondyloarthropathies.
    Turner MJ; Colbert RA
    Curr Opin Rheumatol; 2002 Jul; 14(4):367-72. PubMed ID: 12118169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recognition of HLA-B27 by human CD4(+) T lymphocytes.
    Boyle LH; Goodall JC; Opat SS; Gaston JS
    J Immunol; 2001 Sep; 167(5):2619-24. PubMed ID: 11509603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of HLA-B27 in spondyloarthropathies?
    Chatzikyriakidou A; Voulgari PV; Drosos AA
    Autoimmun Rev; 2011 Jun; 10(8):464-8. PubMed ID: 21296192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oxidative folding and misfolding of human leukocyte antigen-b27.
    Antoniou AN; Guiliano DB; Lenart I; Burn G; Powis SJ
    Antioxid Redox Signal; 2011 Aug; 15(3):669-84. PubMed ID: 21671754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of ankylosing spondylitis: current concepts.
    Smith JA; Märker-Hermann E; Colbert RA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):571-91. PubMed ID: 16777583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis.
    Galocha B; de Castro JA
    Arthritis Rheum; 2008 Feb; 58(2):401-12. PubMed ID: 18240209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B27 lacking associated beta2-microglobulin rearranges to auto-display or cross-display residues 169-181: a novel molecular mechanism for spondyloarthropathies.
    Luthra-Guptasarma M; Singh B
    FEBS Lett; 2004 Sep; 575(1-3):1-8. PubMed ID: 15388324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
    Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
    Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.